Abstract:Niemann–Pick Type C (NPC) represents an autosomal recessive disorder with an incidence rate of 1 in 150,000 live births, classified within lysosomal storage diseases (LSDs). The abnormal accumulation of unesterified cholesterol characterizes the pathophysiology of NPC. This phenomenon is not unique to NPC, as analogous accumulations have also been observed in Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders. Interestingly, disturbances in the folding of the mutant protein NPC1 I1061T are accompanied by the aggregation of proteins such as hyperphosphorylated tau, α-synuclein, TDP-43, and β-amyloid peptide. These accumulations suggest potential disruptions in proteostasis, a regulatory process encompassing four principal mechanisms: synthesis, folding, maintenance of folding, and protein degradation. The dysregulation of these processes leads to excessive accumulation of abnormal proteins that impair cell function and trigger cytotoxicity. This comprehensive review delineates reported alterations across proteostasis mechanisms in NPC, encompassing changes in processes from synthesis to degradation. Additionally, it discusses therapeutic interventions targeting pharmacological facets of proteostasis in NPC. Noteworthy among these interventions is valproic acid, a histone deacetylase inhibitor (HDACi) that modulates acetylation during NPC1 synthesis. In addition, various therapeutic options addressing protein folding modulation, such as abiraterone acetate, DHBP, calnexin, and arimoclomol, are examined. Additionally, treatments impeding NPC1 degradation, exemplified by bortezomib and MG132, are explored as potential strategies. This review consolidates current knowledge on proteostasis dysregulation in NPC and underscores the therapeutic landscape targeting diverse facets of this intricate process.

Endogenous Protein-Protein Interaction Network of the NPC Cholesterol Transporter 1 in the Cerebral Cortex

Abnormal gene expression in cerebellum of Npc1−/− mice during postnatal development

Diversity of glycosphingolipid GM2 and cholesterol accumulation in NPC1 patient-specific iPSC-derived neurons.

Alterations in Proteostasis Mechanisms in Niemann–Pick Type C Disease

Mutant induced neurons and humanized mice enable identification of Niemann-Pick type C1 proteostatic therapies

Neurodegeneration in Niemann-Pick type C disease mice

Endo-lysosomal dysfunction and neuronal–glial crosstalk in Niemann–Pick type C disease

Cutting Edge: Impaired Glycosphingolipid Trafficking and NKT Cell Development in Mice Lacking Niemann-Pick Type C1 Protein

Coordinate Regulation of Mutant NPC1 Degradation by Selective ER Autophagy and MARCH6-dependent ERAD.

A novel approach to analyze lysosomal dysfunctions through subcellular proteomics and lipidomics: the case of NPC1 deficiency

NPC1 links cholesterol trafficking to microglial morphology via the gastrosome

Niemann-Pick Type C1 Protein Influences the Delivery of Cholesterol to the SREBP: SCAP Complex

Decreased Purinergic Inhibition of Synaptic Activity in a Mouse Model of Niemann‐Pick Disease Type C

Myeloid cell–specific loss of NPC1 in mice recapitulates microgliosis and neurodegeneration in patients with Niemann-Pick type C disease

Molecular Characterization of the NPC1L1 Variants Identified from Cholesterol Low Absorbers

Myelin Defects in Niemann–Pick Type C Disease: Mechanisms and Possible Therapeutic Perspectives

3.3 Å Structure of Niemann-Pick C1 Protein Reveals Insights into the Function of the C-terminal Luminal Domain in Cholesterol Transport.

Differential Interferon Signaling Regulation and Oxidative Stress Responses in the Cerebral Cortex and Cerebellum Could Account for the Spatiotemporal Pattern of Neurodegeneration in Niemann–Pick Disease Type C

Accumulation of alkyl-lysophosphatidylcholines in Niemann-Pick disease type C1

Defects of Synaptic Vesicle Turnover at Excitatory and Inhibitory Synapses in Niemann–Pick C1-deficient Neurons

Development and Validation of a New Genotype-Phenotype Correlation for Niemann-Pick Disease Type C1